MedPath

Nicardipine Hydrochloride

These highlights do not include all the information needed to use Nicardipine hydrochloride injection, USP safely and effectively. See full prescribing information for Nicardipine hydrochloride injection. Nicardipine hydrochloride injection, USP, for intravenous use Initial U.S. Approval: 1988

Approved
Approval ID

e61159ba-ff6b-4696-a642-4f64c79c4708

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 11, 2023

Manufacturers
FDA

Wockhardt USA LLC.

DUNS: 170508365

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Nicardipine Hydrochloride

PRODUCT DETAILS

NDC Product Code64679-631
Application NumberANDA090671
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateMarch 11, 2023
Generic NameNicardipine Hydrochloride

INGREDIENTS (5)

CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
NICARDIPINE HYDROCHLORIDEActive
Quantity: 2.5 mg in 1 mL
Code: K5BC5011K3
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Nicardipine Hydrochloride - FDA Drug Approval Details